D151. The Gender-Q: A Rigorous, Modular, Patient-reported Outcome Measure For Gender-affirming Care

Le résumé fourni par la source

PURPOSE: To develop a comprehensive, rigorous PROM to assess outcomes of gender-affirming care in clinical practice, research, and quality initiatives (the GENDER-Q) METHODS: A mixed-methods, multiphase approach was used. In phase 1, in-depth interviews were conducted with adults seeking gender-affirming care from 4 countries (US, Canada, Denmark, Netherlands). Data were analyzed and used to develop a conceptual framework and item pool, which was used to develop preliminary scales. Iterative feedback was sought from clinicians and patients on the scales, and used to refine/develop new scales. The scales were pilot-tested using a crowd-sourcing platform. RESULTS: Data from interviews with 84 transgender and gender diverse adults (34±14years) resulted in 42 preliminary scales that were developed covering the concepts in the conceptual framework. Feedback from 50 clinicians and patient participants (n=7 to 14, depending on scale) was used to refine and develop 15 new scales, resulting in 55 scales in the field test version. Pilot-test was completed (n=602) and used to make minor changes to the GENDER-Q (e.g., drop items). CONCLUSION: The GENDER-Q was developed using extensive input from TGD individuals and clinician experts and represents the most comprehensive set of independently functioning, unidimensional scales that are available to-date. Phase 2 involves an international field-test (currently underway; n=1900), following which the scales will be made available at no charge for academic and clinical research.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.